Tel: 123.456.7890

Shuang Liu, PhD, Founder & CEO  Co-inventor of CSTI-500. 20 years of experience in drug R&D as an integrated project leader. Led AMRI’s triple monoamine program that delivered 4 NCEs, including CSTI-500, for clinical development. Led other successful discovery programs in CNS, oncology, and autoimmune at AMRI. Co-Inventor of >30 patent families. PhD in organic chemistry from the University of Georgia with postdoc training at Emory University. 

John Maki, Acting President  30 years of management and investment experience in life science. Formerly CEO of Vicus Therapeutics a clinical-stage immuno-oncology company, Managing Director at TDI and Audax Group, Principal at Bain Capital and Consultant at Bain & Company. Mr. Maki serves on the boards of Vicus Therapeutics and 3DMatrix as well as the Board of Trustees of BIO NJ. AB in Economics from Harvard University. 

Roman Dvorak, MD, PhD, Chief Medical Officer Over 25 years of clinical development, global regulatory leadership, and business development experience. Former CMO at Saniona where he led PWS and HO clinical trials of Tesomet. Also involved with Qnexa® & Meridia® clinical studies whilst holding senior roles at Vivus and Knoll, respectively. Roman has held other senior roles with Pfizer and J&J amongst others, and has specialist expertise in endocrinology & metabolic disorders.

Lois Rosenberger, PhD, Head of Regulatory  President of LBR Regulatory and Clinical Consulting Services. 30+ years of regulatory, quality assurance, and 20+ years of experience in managing clinical trials including for PWS. Lois held regulatory leadership positions at Kendle CRO, Marion-Merrell Dow, and P&G.  

Allen Ritter, PhD, Contract CMC  30 years of experience in the development, manufacturing, outsource manufacturing, and registration of pharmaceuticals. Former VP Manufacturing/CMC at Endocyte and CMC/QA management positions at Eli Lilly.   

Phone Number

+1 (518) 275-0176

Email Address


Health Sciences Campus

11 University Place

Rensselaer, NY 12144

Consynance Logo.png

Sign Up for ConSynance Updates

Get our news and updates on our progress and upcoming events.

© ConSynance Therapeutics | All Rights Reserved 2019